Ionis Pharmaceuticals, Inc. (IONS)
75.17
-4.28
(-5.39%)
USD |
NASDAQ |
Mar 05, 16:00
75.17
0.00 (0.00%)
After-Hours: 18:49
Ionis Pharmaceuticals Cash from Investing (TTM) : -277.78M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Biogen, Inc. | -1.371B |
| Alnylam Pharmaceuticals, Inc. | 436.33M |
| Geron Corp. | 107.25M |
| MannKind Corp. | -304.80M |
| Twist Bioscience Corp. | -33.16M |